Return on Equity (ROE)
Updated 8h ago
Sector Performance
52th percentileNTRS
14.5%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
A Return on Equity (ROE) of 14.5% means that for every dollar of shareholder equity, the company earned $0.145 in profit last year — a measure of how efficiently it uses investors’ money.
This sits slightly above the sector median of 13.8%, placing NTRS in the 52nd percentile among its peers, so performance is near the middle of the pack. The trend is not available: the year-over-year change, quarter-over-quarter change, and direction over the last eight quarters are all listed as N/A, providing no insight into improvement or decline. Because the ROE level is only marginally above average and no trend data exists, the metric offers a neutral signal — neither a clear opportunity from rising returns nor a risk from falling ones. This aligns with the overall NEUTRAL verdict, as the metric neither strengthens nor weakens the case for the stock without historical context to judge momentum.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about NTRS?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are NTRS's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master NTRS's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full NTRS research report →NTRS
14.5%
Sector Median
13.8%
Sector Avg
31.4%
How NTRS's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.